Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Shelden

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Trials|August 26, 2018
Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients - study protocol for a randomized controlled trialAlexandra Halalau, Daniel Shelden, Scott Keeney, et al.
JCEM Case Reports|August 7, 2024
Neurosarcoidosis With Panhypopituitarism: Two Cases and Literature ReviewEwelina Niedzialkowska, Tatjana Blazin, Daniel Shelden, et al.
Clinical Diabetes and Endocrinology|November 30, 2020
A virtual teaching clinic for virtual care during the COVID-19 pandemicXin He, Daniel Shelden, Andrew Kraftson, et al.
Respirology Case Reports|April 25, 2017
A hol(e)y predicamentShaiva Ginoya Meka, Daniel Shelden, Amy Mertens, et al.
Journal of Diabetes Science and Technology|December 23, 2020
Improving Hospital Glucometrics, Workflow, and Outcomes with a Computerized Intravenous Insulin Dose Calculator Built into the Electronic Health RecordDaniel Shelden, Mohammed Ateya, Angela Jensen, et al.
The American Journal of Managed Care|April 25, 2018
Impact of a pharmacist-managed diabetes clinic on quality measuresNadia J Aneese, Alexandra Halalau, Sarah Muench, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Trials|August 26, 2018
Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients - study protocol for a randomized controlled trialAlexandra Halalau, Daniel Shelden, Scott Keeney, et al.
JCEM Case Reports|August 7, 2024
Neurosarcoidosis With Panhypopituitarism: Two Cases and Literature ReviewEwelina Niedzialkowska, Tatjana Blazin, Daniel Shelden, et al.
Clinical Diabetes and Endocrinology|November 30, 2020
A virtual teaching clinic for virtual care during the COVID-19 pandemicXin He, Daniel Shelden, Andrew Kraftson, et al.
Respirology Case Reports|April 25, 2017
A hol(e)y predicamentShaiva Ginoya Meka, Daniel Shelden, Amy Mertens, et al.
Journal of Diabetes Science and Technology|December 23, 2020
Improving Hospital Glucometrics, Workflow, and Outcomes with a Computerized Intravenous Insulin Dose Calculator Built into the Electronic Health RecordDaniel Shelden, Mohammed Ateya, Angela Jensen, et al.
The American Journal of Managed Care|April 25, 2018
Impact of a pharmacist-managed diabetes clinic on quality measuresNadia J Aneese, Alexandra Halalau, Sarah Muench, et al.
Pageof 1